Dr. Joshua Schiffman is a pediatric oncologist at Huntsman Cancer Institute at the University of Utah. He attended the Brown University School of Medicine, followed by pediatric residency and chief residency at the Stanford University School of Medicine. He completed his fellowship training in Pediatric Hematology/Oncology also at Stanford University. Dr. Schiffman's research focuses on the development of pediatric cancer and he runs a translational genomics laboratory that works to identify which children are at risk for cancer and why. Dr. Schiffman serves as the Medical Director for the High Risk Pediatric Cancer Clinic run jointly through Primary Children's Medical Center and Huntsman Cancer Institute at the University of Utah. Through this clinic, Dr. Schiffman cares for children and families at risk for hereditary cancer syndrome and using state of the art imaging technology, Dr. Schiffman and colleagues have been able to identify and remove tumors in patients before they even present with symptoms. Dr. Schiffman also serves as the Education Director for the Program in Personalized Health Care at the University of Utah where he oversees the teaching of translational and individualized clinical medicine based on cutting-edge genomic information now available to physicians and their patients. Dr. Schiffman is a member of several international pediatric cancer organizations, including serving as the Working Group Leader for the Familial Leukemia Section of the Childhood Leukemia International Consortium (CLIC) and the Working Group Leader for the Clinical Section of the International Childhood Cancer Cohort Consortium (I4C). Both of these organizations bring cancer and epidemiology experts together from around the world with the singular goal of understand the genetic and environmental origins of pediatric cancer.